07-Oct-2026 18:00:03
INDRANIBGeneral news
INDRAYANI BIOTECH LTD : CONS NET PROFIT UP 31.6% AT 54 CR (YOY), DOWN 44.3% (QOQ).
• Revenue from operations up 29.6% at 3,929.65 Cr (YOY), up 1.7% (QOQ). • Total Comprehensive Income up 39.8% at 54 Cr (YOY). • Basic EPS at ₹0.06 v ₹0.02 (YOY), ₹0.03 (QOQ). Impact: Company reported mixed results for Q2.
Indrayani Biotech Ltd
Open attachment